CIK 0001275187 · Accelerated filer
ANGIODYNAMICS INC
Sign in to watch- Ticker
- ANGO
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- May 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 113146460
- Phone
- 5187981215
- Business address
- 14 PLAZA DRIVE, LATHAM, NY, 12110
- DEFA14A Proxy Proxy Materials
- 10-Q Report Quarterly Report
- 4 Open-market buy President and CEO bought 10,000 shares at $15.00 ($150,000)
- 8-K Event Other events
- 8-K Event Results of operations · Regulation FD disclosure
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 8-K Event Material agreement · Agreement ended · New debt or obligation
- 8-K Event Regulation FD disclosure
- 4 Open-market sale SVP Global Operations and R&D sold 5,000 shares at $22.44 ($112,200)
- 4 Grant or award President and CEO acquired 33,094 shares (grant or award)
- 4 Grant or award SVP/GM, Vascular Access acquired 3,987 shares (grant or award)
- 4 Grant or award SVP Quality and Regulatory acquired 3,426 shares (grant or award)
- 4 Grant or award SVP Global Operations and R&D acquired 3,691 shares (grant or award)
- 4 Grant or award SVP International acquired 4,402 shares (grant or award)
- 4 Grant or award SVP and General Counsel acquired 3,963 shares (grant or award)
- 4 Grant or award EVP and CFO acquired 7,961 shares (grant or award)
- 4 Grant or award SVP/GM, VIT acquired 3,705 shares (grant or award)
- 4 Grant or award Director acquired 7,060 shares (grant or award)
- 4 Grant or award Director acquired 7,060 shares (grant or award)
Page 13 of 85 · 1,685 filings